ALANA SILVERMAN: Open Payments
NPI 1609383041 · ORONO, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$994 in 45 payments from 11 companies in 2025. Trend: 2023 $2,105 · 2024 $653 · 2025 $994
Food & beverage: $909Education: $85
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $224 |
| UCB, Inc. | 1 | $160 |
| ABBVIE INC. | 29 | $147 |
| Janssen Biotech, Inc. | 2 | $125 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $105 |
| Arcutis Biotherapeutics, Inc. | 1 | $83 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| Galderma Laboratories, L.P. | 2 | $31 |
| Biofrontera Inc. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, TREMFYA, Zoryve, Rhapsido, NEMLUVIO, AMELUZ.
Industry payments across ME — which companies pay providers there.
